
关爱胃忧危害
健胃专用益生菌
Probiotics for gastroprotection
抑制胃幽门螺旋杆菌
修复受损黏膜
缓解胃部不适


专利认证
用于治疗胃溃疡之乳酸菌菌株之食品组合物以及医药组合物
中国发明号ZL201110179109.2
中国台湾发明号I384990
建议剂量
1.8×1010CFU/Day

参考文献
1. 从健康人体中分离出之乳酸菌,筛选抗幽门螺旋杆菌之菌株。
Eradication effects of probiotic strains isolated from human feces on Helicobacter pylori. in The 5th Asian Conference on Lactic Acid Bacteria. 2010. P64.
2. 益生菌可降低胃酸的分泌,改善其症状与尿素酶的活性。
Eradication effects of probiotic strains isolated from human feces on Helicobacter pylori. The 6th Asian Conference on Lactic Acid Bacteria. 2011. P-AM15-50.
3. 具潜力有效抑制幽门螺旋杆菌之益生菌株,降低感染的危险性。
Eradication of Helicobacter sp. Infection by the probiotics strains Lactobacillus johnsonii MH-68 and L. salivarius spp. Salicinius AP-32. Helicobacter. 2012. 17(6):466-77.
4. 唾液乳杆菌AP-32经细胞实验及动物实验证实,在致病菌感染期间能修复胃部及肠道屏障。
Defense of pathogen infection via modulation of tight junction protein by the probiotic strain L. salivarius ssp. salicinius AP-32. The 6th International Conference on Food Factors. 2015. P0482.
5. 唾液乳杆菌、嗜酸乳杆菌及植物乳杆菌三联活菌制剂根除幽门螺杆菌的临床研究。
Study of Lactobacillus salivarius, Lactobacillus acidophilus and Lactobacillus Triple Viable Capsules Combined with Triple Therapy for Helicobacter Pylori Eradication. Medical Innovation of China. 2017. 14(10):P036-039.
6. 益生菌冻干粉联合铋剂四联疗法治疗幽门螺旋杆菌感染的临床效果。
Clinical effect of Probiotics Freeze-Dried Powder combined with bis-muth-containing quardruple therapy in the treatment of Helicobacter Pylori infection. China Modern Medicine. 2018. Vol.25, No.23 :P155-157.

健康从肠计划
肠道专用益生菌
Probiotics for intestinal health
肠道菌群平衡
修复受损黏膜
增强肠道屏障


专利认证
新颖乳酸菌株及其调节免疫反应的用途
中国发明号ZL201310269240.7
中国台湾发明号I429444
建议剂量
1.8×1010亿CFU/Day

参考文献
1. 益生菌保护人体黏膜以抑制致病菌生长。
Inhibition of in vitro growth of pathogens to protect human mucosae by probiotics. CIFST. 2012; P2-18.
2. 乳双歧杆菌与鼠李糖乳杆菌三联活菌制剂联合治疗小儿轮状病毒肠炎的疗效及对免疫功能的影响。
Clinical effects for patients with rotaviral enteritis by Bifidobacterium combined with Lactobacillus rhamnosus and the influence on the immune function. Medical innovation of China. 2016, 13(06): 059-062
3. 补充双歧杆菌与鼠李糖乳杆菌三联活菌制剂对肠道手术后肠道菌群的影响。
Effects of supplemented Bifidobacterium and Lactobacillus acidophilus triple living bacteria preparation on intestinal flora after intestinal surgery. CHINA MODERN MEDICINE Vol. 24 No. 5 February 2017.
4. 乳酸菌对超广谱酶大肠杆菌 ( ESBL)的抑菌活性。
Bacteriostatic activities of lactic acid bacteria against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):1-2.
5. 活乳酸菌与热灭活乳酸菌对抗药性金黄葡萄球菌(MRSA) 之抑菌效果。
Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicillin-resistant Staphylococcus aureus. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):14-15.
6. 后生元PE0401及十益菌PF1001可调控肠道菌群并缓解离乳猪腹泻。
The Postbiotics, Totipro PE0401, and Probiotic Mixture, PF1001, Modulate the Gut Microbiota and Ameliorate Diarrhea in Weaning Piglets.Biomedical Journal of Scientific & Technical Research. 2020
本网站涉及的有关益生菌对人体健康影响的公开科学数据、文章及任何内容,均为针对益生菌本身已经科学验证的数据,非我公司产品之宣传。我公司产品不用于诊断、治疗、或预防任何疾病。
版权所有 © 锦乔生物科技有限公司 苏ICP备19002290号-2 营业执照 本网站已支持IPV6
留下联系方式,获取资料